The U.S. Centers for Disease Control and Prevention (CDC) has updated recommended vaccine schedules for children, adolescents and adults to include the COVID-19 biologics. The move is consistent with recommendations made by the agency’s Advisory Committee on Vaccine Practices (ACIP) in October 2022.1 2 3 4 5 The update of the recommended vaccination schedules was […]
Biotechnology company Novavax announced that it has made a modification to an existing contract with the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DoD) to provide up to 1.5 million more doses of its Nuvaxovid COVID-19 vaccine (also known as “NVX-CoV2373” and “Covovax”), in addition to the 3.2 million […]
According to the Department of Health in New Brunswick, Canada, 1,148 people living in that province suffered an adverse reaction after receiving a COVID-19 shot between Dec. 14, 2020 and Jan. 14, 2023. It was reported that 313 of the reactions were considered “serious.”1 Health Canada, the department of the Canadian government responsible for national health […]
On Jan. 12, 2023, Japan’s Ministry of Health, Labor and Welfare (MHLW) approved lump sum monetary payments to the families of five people in the country who died after getting COVID shots. Each payment is valued at ¥44.2 million ($345,677), and there is also a ¥212,000 ($1,658) contribution for funeral expenses.1 2 3 The five […]
Nearly two years after the introduction of COVID-19 biologics around the world, the pharmaceutical industry is facing a waning demand for these products. Scott Rosenstein, a New York-based health care adviser to Eurasia Group said: Supply is exceeding demand in much of the world, even with many countries rolling out booster shots. Once the perception set […]
Froedtert Health, a health care system headquartered in Wauwatosa, Wisconsin, is withdrawing religious and medical exemptions held by employees who had originally refused to get the messenger RNA (mRNA) COVID-19 shots. The company informed its employees that they must now get vaccinated with the recently approved Novavax’s COVID vaccine NVX-CoV2373 (also known as “Nuvaxovid” and […]
Techniker Krankenkasse, Germany’s largest health insurance company, reported that 437,593 of 11 million (1 in 25) insured individuals in 2021 had to undergo medical treatment as a result of adverse reactions from COVID-19 shots.1 COVID shots currently approved for use in Germany include Novavax’s Nuvaxovid, Moderna’s Spikevax, Pfizer/BioNTech’s Comirnaty, Johnson & Johnson/Janssen’s Ad26.COV2.S, AstraZeneca/Oxford University’s […]
On July 25, 2022, a committee of Japan’s Ministry of Health, Labor and Welfare announced that it would provide a lump-sum death benefit of ¥44.2 million ($324,000), plus an additional ¥212,000 for funeral expenses, to the family of an elderly woman who died shortly after receiving a COVID-19 shot. The committee determined there was a […]
For a virus (SARS-CoV-2) that many scientists and public health officials have maintained originated in a bat and accidently crossed over into humans, leading to the COVID-19 pandemic, it is odd that there does not appear to be much concern about producing vaccines that use genetic material from animals. You would think that this would […]
Opinion | On July 13, 2022, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Novavax to distribute its experimental two-dose NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine for use by adults. The decision was expected, given the favorable recommendation by the FDA’s Vaccines and Related Biological Products Advisory […]